Results 21 to 30 of about 13,742 (225)

The impact of adenomyosis on IVF outcomes: a prospective cohort study

open access: yes, 2021
STUDY QUESTION: Does the presence of adenomyosis in women treated with IVF alter IVF outcomes? SUMMARY ANSWER: Adenomyosis does not significantly alter IVF outcomes when adjusted for confounding factors including maternal age and smoking status.
Vollenhoven, B   +5 more
core   +1 more source

Women with adenomyosis are at higher risks of endometrial and thyroid cancers: A population-based historical cohort study.

open access: yesPLoS ONE, 2018
ObjectiveBoth adenomyosis and endometriosis are characterized by the presence of ectopic endometrial glands and stroma and have been suggested to share some characteristics with malignant tumors.
Chih-Ching Yeh   +4 more
doaj   +1 more source

Effect of atosiban on in vitro fertilization pregnancy outcome among women with endometriosis in presence or absence of adenomyosis

open access: yesTaiwanese Journal of Obstetrics & Gynecology, 2023
Objective: This study aimed to assess the effect of atosiban on in vitro fertilization (IVF) pregnancy outcome among women with both endometriosis and adenomyosis, and compared it to that of patients with endometriosis but without adenomyosis and that of
Chih-Wei Lin   +4 more
doaj   +1 more source

Pathophysiology of adenomyosis [PDF]

open access: yesHuman Reproduction Update, 1998
Adenomyosis refers to endometrial glands and stroma located haphazardly deep within the myometrium. Similar histological alterations may be found in extrauterine locations such as the rectovaginal septum. The aetiology and pathogenic mechanism(s) responsible for adenomyosis are poorly understood. Both human and experimental studies favour the theory of
openaire   +2 more sources

Adenomyosis among samples from hysterectomy due to abnormal uterine bleeding in Ahwaz, southern Iran

open access: yesAdvanced Biomedical Research, 2012
Introduction: Adenomyosis is one of the most common, yet underdiagnosed, underlying causes of abnormal uterine bleeding (AUB). We aimed to evaluate the prevalence of adenomyosis among subjects who underwent hysterectomy due to AUB.
Maryam Dehghani Mobarakeh   +2 more
doaj   +1 more source

Epidemiology of Adenomyosis

open access: yesSeminars in Reproductive Medicine, 2020
AbstractAdenomyosis, characterized by the presence of endometrial glands and stroma within the myometrium, can have a substantial impact on the quality of women's lives. Despite this, the epidemiologic research on this condition lags considerably behind that of other noncancerous reproductive health conditions. The lack of progress and knowledge is due
Kristen Upson, Stacey A. Missmer
openaire   +3 more sources

Intrauterine cystic adenomyosis [PDF]

open access: yes, 2022
The authors described a rare variant of adenomyosis — intrauterine cystic adenomyosis. A review of the literature on the frequency, classification, features of diagnosis and surgical treatment of cystic adenomyosis is presented.Autorii au descris o ...
Mişina, Ana, Petrovici, V.
core  

The Endometrium in Adenomyosis

open access: yesWomen's Health, 2012
Eutopic and ectopic endometria of women with adenomyosis show a series of metabolic and molecular abnormalities that increase angiogenesis and proliferation, decrease apoptosis, allow local production of estrogens, create progesterone resistance, and impair cytokine expression.
Benagiano, Giuseppe, Brosens, Ivo
openaire   +3 more sources

Adenomyosis is an independent risk factor for complications in deep endometriosis laparoscopic surgery

open access: yesScientific Reports, 2022
Deep endometriosis (DE) occurs in 15–30% of patients with endometriosis and is associated with concomitant adenomyosis in around 25–49% of cases.
Meritxell Gracia   +9 more
doaj   +1 more source

Increased Matrix Metalloproteinase-2 and Tissue Inhibitor of Metalloproteinase-1 Secretion but Unaffected Invasiveness of Endometrial Stromal Cells in Adenomyosis

open access: yes, 2011
Objective: To investigate cell invasiveness and the production of matrix metalloproteinase-2 (MMP-2), MMP-9, tissue inhibitor of metalloproteinase- 1 (TIMP-1) and TIMP-2 in endometrial stromal cells (ESCs) of adenomyosis.
楊政憲;吳明義;陳美州;陳思原;楊友仕;何弘能   +1 more
core   +1 more source

Home - About - Disclaimer - Privacy